Business Context and Reporting Period
This Form 8-K was filed by PerkinElmer, Inc. (now REVVITY, INC.) on January 31, 2017. The report details a strategic realignment of operating segments effective October 3, 2016, creating the Diagnostics segment and the Discovery & Analytical Solutions segment. Additionally, on December 21, 2016, the Company entered into an agreement to sell its Medical Imaging business to Varian Medical Systems, Inc., classifying this business as discontinued operations.
Key Financial Metrics
The filing does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Instead, it announces the availability of unaudited historical financial data on the Company's Investor Relations website. This data retrospectively reflects the new segment structure and the exclusion of the Medical Imaging business for the twelve months ended January 3, 2016, and various quarterly periods through October 2, 2016.
Material Changes
- Segment Restructuring: The Company realigned operations into two new segments to improve customer focus and innovation.
- Discontinued Operations: The Medical Imaging business has been placed into discontinued operations following the sale agreement with Varian.
- Reporting Impact: The Annual Report on Form 10-K for the fiscal year ended January 1, 2017, will be the first periodic report to reflect these structural changes.
Guidance, Outlook, and Risks
Management commentary indicates the strategic intent to grow in attractive end markets and expand market share through the new segment structure. The filing includes a standard Regulation FD disclosure stating that the information provided is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated. No specific forward-looking guidance, risk factors, or contingencies regarding the transaction are detailed in this text.
Investor Verification Checklist
- Verify the unaudited historical financial data available on the Investor Relations website (ir.perkinelmer.com) to understand the financial impact of the segment realignment.
- Confirm the final terms and closing status of the Master Purchase and Sale Agreement with Varian Medical Systems, Inc.
- Review the upcoming Form 10-K for the fiscal year ended January 1, 2017, for the first official presentation of the new segment structure.